+
+
Stay Informed
Clinical Data

BETTER EVIDENCE TO BUILD CONFIDENCE

Abbott provides a robust body of clinical evidence encompassing clinical data and outcomes from tens of thousands of patients across our structural heart portfolio of products.*

IN-DEPTH DATA ABOUT ABBOTT STRUCTURAL HEART PRODUCTS

With our clinical insights and bulletins, you can take a deeper dive into clinical outcomes related to Abbott Structural Heart products. Designed for ease of viewing, these pieces give you a broader perspective about study outcomes, along with product safety and performance.

Transcatheter Valve Solutions

  • Hemodynamic Monitoring during MitraClip Procedures
    MITRACLIP™ FOR TMVr**

    Hemodynamic Monitoring during MitraClip™ Procedures

    Read more
  • Cardiovascular Physiology in Mitral Regurgitation for MitraClip
    MITRACLIP™ FOR TMVr**

    Cardiovascular Physiology in Mitral Regurgitation

    Read more
  • The bRIGHT study to evaluate the TriClip TEER System for tricuspid therapy
    TRICLIP™ FOR TEER

    The future of tricuspid therapies is bRIGHT

    Read more
  • The TRILUMINATE study design for the TriClip TEER System
    TRICLIP™ FOR TEER

    Meaningful outcomes backed by robust evidence

    Read more

TAVI Solutions

  • Portico valve meets non-inferiority criteria for safety and efficacy in two-year analysis
    PORTICO™ FOR TAVI

    Portico™ Valve Meets Non-Inferiority Criteria for Safety and Efficacy in Two-Year Analysis1

    Read more
  • Portico valve demonstrates consistent results at two years
    PORTICO™ FOR TAVI

    Portico™ Valve Demonstrates Consistent Results at Two Years1

    Read more
  • TAVI and Prosthesis-Patient Mismatch (PPM) in the Small Aortic Annulus (SAA)
    PORTICO™ FOR TAVI

    TAVI and Prosthesis-Patient Mismatch (PPM) in the Small Aortic Annulus (SAA)

    Read more

Structural Interventions

  • Clinical insight into Amplatzer Amulet LAAO for reducing risk of ischemic stroke in AF
    AMPLATZER™ AMULET™ LAA OCCLUDER

    LAAO for reducing risk of ischemic stroke in AF

    Read more
  • PFO closure or medical therapy in patients with PFO and cryptogenic stroke
    AMPLATZER™ PFO OCCLUDER

    PFO closure or medical therapy in patients with PFO and cryptogenic stroke

    Read more
  • European position paper on the management of patients with patent foramen ovale (PFO)
    AMPLATZER™ PFO OCCLUDER

    European position paper on the management of patients with patent foramen ovale (PFO)

    Read more
  • Cardiac erosion after ASD closure with the Amplatzer Atrial Septal Occluder (ASO) device
    AMPLATZER™ ATRIAL SEPTAL OCCLUDER

    Cardiac erosion after ASD closure with the ASO device

    Read more
  • Amplatzer Septal Occluder safety clinical insights
    AMPLATZER™ ATRIAL SEPTAL OCCLUDER

    Amplatzer™ Septal Occluder safety

    Read more
  • Advantages of the Intaglio wire treatment of the Amplatzer Occluders
    THE INTAGLIO™ WIRE TREATMENT

    Advantages of the Intaglio™ wire treatment of the Amplatzer™ Occluders

    Read more

Surgical Valve Solutions

  • Epic Mitral – Ten Year Clinical Outcomes of SMVR in a Medicare Population
    EPIC™ MITRAL STENTED TISSUE VALVE WITH LINX™ AC TECHNOLOGY

    Epic Mitral – Ten Year Clinical Outcomes of SMVR in a Medicare Population2

    Read more
  • Clinical studies find consistent durability in Epic Mitral Valve tested over 35 years
    EPIC™ MITRAL STENTED TISSUE VALVE WITH LINX™ AC TECHNOLOGY

    Epic Mitral Continues the Biocor Legacy: Strength of Design, Tested Over 35 Years2

    Read more

CLINICAL DATA | STRUCTURAL INTERVENTIONS

MAT-2004712 v2.0 | Item approved for Global OUS use only.

References

*Data on File at Abbott
**TMVr is now referred to as TEER (Transcatheter edge-to-edge repair)

  1. Sondergaard L, on behalf of the PORTICO I investigators. Two year outcomes in the Portico I study. Presented at: PCR London Valves 2019. November 18, 2019. London, England.
  2. Rodriguez, E. et. al. (2022, January). Ten-Year Outcomes of a Contemporary Generation Low-Profile Porcine Mitral Bioprosthesis in a Medicare Population. Poster presented at the STS Annual Meeting, Virtual.
Abbott Logo

Making an everlasting
impact On human health
for 130 years

Follow Abbott

Copyright © 2022 Abbott, 3200 Lakeside Dr, Santa Clara, 95054, U.S.A.
Caution: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or at eifu.abbottvascular.com or at medical.abbott/manuals for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.
Illustrations are artist’s representations only and should not be considered as engineering drawings or photographs. Photos on file at Abbott.
Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

MAT-2000631 v8.0 | Item approved for Global OUS use only.

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.

U.S. Health Care Professionals International Health Care Professionals

YOU ARE ABOUT TO LEAVE
www.structural­heart.abbott

You are now leaving www.structuralheart.abbott. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

OkCancel